Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)
Clinical trial NCT00377065 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00377065
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.